RecruitingNCT05247112
Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
Sponsor
Seoul National University Bundang Hospital
Enrollment
2,000 participants
Start Date
Jul 1, 2003
Study Type
OBSERVATIONAL
Conditions
Summary
To assess antimicrobial resistance rates and minimal inhibitory concentrations in H. pylori isolated from patients with upper gastrointestinal disease with long-term period.
Eligibility
Inclusion Criteria1
- Subjects who had a H. pylori infection and had consented to undergo culture analysis via endoscopic resection, in order to determine the minimal inhibitory concentration (MIC) of various antibiotics.
Exclusion Criteria1
- Patients with a concurrent critical illness, who abused drugs or alcohol, who were pregnant or nursing, or those who had received antibiotics, PPIs, or bismuth salts within 4 weeks, were excluded.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05247112
Related Trials
Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication
NCT074394451 location
Tegoprazan-containing Sequential for H. Pylori
NCT063824931 location
Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication
NCT075376342 locations
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT053324441 location
Effect of PPIs on Stool DNA Test for H. Pylori
NCT075162621 location